Of mice and men, revisited: new insights into an ancient molecule from studies of complement activation by Cryptococcus neoformans.
作者信息
Pirofski Liise-Anne
机构信息
Division of Infectious Diseases, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.
出版信息
Infect Immun. 2006 Jun;74(6):3079-84. doi: 10.1128/IAI.00431-06.
Abstract
摘要
相似文献
1
Of mice and men, revisited: new insights into an ancient molecule from studies of complement activation by Cryptococcus neoformans.《人鼠之间》再探讨：从新型隐球菌补体激活研究中获得的关于一种古老分子的新见解
Infect Immun. 2006 Jun;74(6):3079-84. doi: 10.1128/IAI.00431-06.
2
Differential localization of complement component 3 within the capsular matrix of Cryptococcus neoformans.新型隐球菌荚膜基质中补体成分3的差异定位
Infect Immun. 2006 Jun;74(6):3096-106. doi: 10.1128/IAI.01213-05.
3
In vivo complement activation and binding of C3 to encapsulated Cryptococcus neoformans.体内补体激活及C3与荚膜新生隐球菌的结合
Infect Immun. 1992 Sep;60(9):3937-9. doi: 10.1128/iai.60.9.3937-3939.1992.
4
Role of the capsule in phagocytosis of Cryptococcus neoformans.荚膜在新型隐球菌吞噬作用中的作用。
Rev Infect Dis. 1988 Jul-Aug;10 Suppl 2:S436-9. doi: 10.1093/cid/10.supplement_2.s436.
5
Capsular reactions of Cryptococcus neoformans with polyspecific and oligospecific polyclonal anticapsular antibodies.新型隐球菌与多特异性和寡特异性多克隆抗荚膜抗体的荚膜反应
Infect Immun. 2001 Feb;69(2):1189-91. doi: 10.1128/IAI.69.2.1189-1191.2001.
6
Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance.单克隆抗体可通过经典途径激活和空间位阻两种方式影响补体在致病性真菌新型隐球菌荚膜上的沉积。
Cell Microbiol. 2006 Dec;8(12):1862-76. doi: 10.1111/j.1462-5822.2006.00753.x. Epub 2006 Jul 4.
7
Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans.菌株变异、血清型及结构修饰对C3激活及与新型隐球菌结合动力学的影响。
Infect Immun. 1993 Jul;61(7):2966-72. doi: 10.1128/iai.61.7.2966-2972.1993.
8
Opsonic requirements for the uptake of Cryptococcus neoformans by human polymorphonuclear leukocytes and monocytes.人多形核白细胞和单核细胞摄取新型隐球菌的调理素需求。
J Infect Dis. 1982 Jun;145(6):870-4. doi: 10.1093/infdis/145.6.870.
9
Activation of the complement system by the capsule of Cryptococcus neoformans.新型隐球菌荚膜激活补体系统。
Curr Top Med Mycol. 1993;5:1-26.
10
Influence of opsonization conditions on C3 deposition and phagocyte binding of large- and small-capsule Cryptococcus neoformans cells.调理作用条件对大荚膜和小荚膜新生隐球菌细胞C3沉积及吞噬细胞结合的影响。
Infect Immun. 1996 Jun;64(6):2336-8. doi: 10.1128/iai.64.6.2336-2338.1996.
引用本文的文献
1
C1q Confers Protection Against Cryptococcal Lung Infection by Alleviating Inflammation and Reducing Cryptococcal Virulence.C1q通过减轻炎症和降低隐球菌毒力来赋予对隐球菌肺部感染的保护作用。
Open Forum Infect Dis. 2023 Mar 21;10(4):ofad151. doi: 10.1093/ofid/ofad151. eCollection 2023 Apr.
2
Host immunity to Cryptococcus neoformans.宿主对新型隐球菌的免疫
Future Microbiol. 2015;10(4):565-81. doi: 10.2217/fmb.14.132.
3
Current concepts in host-microbe interaction leading to pneumococcal pneumonia.导致肺炎链球菌肺炎的宿主-微生物相互作用的当前概念。
Curr Opin Infect Dis. 2013 Jun;26(3):277-83. doi: 10.1097/QCO.0b013e3283608419.
4
The capsule of the fungal pathogen Cryptococcus neoformans.新型隐球菌这种真菌病原体的荚膜。
Adv Appl Microbiol. 2009;68:133-216. doi: 10.1016/S0065-2164(09)01204-0.
本文引用的文献
1
Differential localization of complement component 3 within the capsular matrix of Cryptococcus neoformans.新型隐球菌荚膜基质中补体成分3的差异定位
Infect Immun. 2006 Jun;74(6):3096-106. doi: 10.1128/IAI.01213-05.
2
Towards a vaccine for Cryptococcus neoformans: principles and caveats.迈向新型隐球菌疫苗：原理与注意事项。
FEMS Yeast Res. 2006 Jun;6(4):525-36. doi: 10.1111/j.1567-1364.2006.00073.x.
3
Estimating the relative contributions of virulence factors for pathogenic microbes.估计致病微生物毒力因子的相对贡献。
Infect Immun. 2006 Mar;74(3):1500-4. doi: 10.1128/IAI.74.3.1500-1504.2006.
4
A protective role for the fifth complement component (c5) in allergic airway disease.补体第五成分（C5）在变应性气道疾病中的保护作用。
Am J Respir Crit Care Med. 2006 Apr 15;173(8):852-7. doi: 10.1164/rccm.200503-334OC. Epub 2006 Jan 26.
5
Feasibility and prospects for a vaccine to prevent cryptococcosis.预防隐球菌病疫苗的可行性与前景
Med Mycol. 2005 Dec;43(8):667-80. doi: 10.1080/13693780500448230.
6
The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding.致病真菌新型隐球菌的多糖荚膜通过远端生长而增大，并在出芽过程中重新排列。
Mol Microbiol. 2006 Jan;59(1):67-83. doi: 10.1111/j.1365-2958.2005.04928.x.
7
The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction.新型隐球菌荚膜多糖的物理特性提示了荚膜构建的特征。
J Biol Chem. 2006 Jan 27;281(4):1868-75. doi: 10.1074/jbc.M509465200. Epub 2005 Nov 8.
8
Cryptococcus neoformans-reactive and total immunoglobulin profiles of human immunodeficiency virus-infected and uninfected Ugandans.乌干达感染和未感染人类免疫缺陷病毒人群的新型隐球菌反应性及总免疫球蛋白谱
Clin Diagn Lab Immunol. 2005 Oct;12(10):1168-76. doi: 10.1128/CDLI.12.10.1168-1176.2005.
9
Structures of complement component C3 provide insights into the function and evolution of immunity.补体成分C3的结构为免疫功能和进化提供了见解。
Nature. 2005 Sep 22;437(7058):505-11. doi: 10.1038/nature04005.
10
Immune regulation during allergic bronchopulmonary mycosis: lessons taught by two fungi.变应性支气管肺真菌病中的免疫调节：两种真菌带来的启示
Immunol Res. 2005;33(1):53-68. doi: 10.1385/IR:33:1:053.
Zotero 插件